Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation
Authors:
- Xiao-Ping WangXWXiao-Ping Wang
- Rui-Tian LiuRLRui-Tian Liu
- 1 November 2009
- journal article
- research article
- Published by Elsevier in NeuroToxicology
- Vol. 30 (6) , 986-995
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- The SIRT1 activator resveratrol protects SK‐N‐BE cells from oxidative stress and against toxicity caused by α‐synuclein or amyloid‐β (1‐42) peptideJournal of Neurochemistry, 2009
- Salvianolic acid B inhibits Aβ fibril formation and disaggregates preformed fibrils and protects against Aβ-induced cytotoxictyNeurochemistry International, 2008
- Insight Into the Kinetic of Amyloid β (1–42) Peptide Self‐Aggregation: Elucidation of Inhibitors’ Mechanism of ActionChemBioChem, 2007
- Conversion of non-fibrillar β-sheet oligomers into amyloid fibrils in Alzheimer’s disease amyloid peptide aggregationBiochemical and Biophysical Research Communications, 2007
- Engineering metal ion coordination to regulate amyloid fibril assembly and toxicityProceedings of the National Academy of Sciences, 2007
- Novel method for quantitative determination of amyloid fibrils of α-synuclein and amyloid β/A4 protein by using resveratrolAnalytical Biochemistry, 2007
- Aβ Oligomers Induce Neuronal Oxidative Stress through an N-Methyl-D-aspartate Receptor-dependent Mechanism That Is Blocked by the Alzheimer Drug MemantineJournal of Biological Chemistry, 2007
- Distinct Early Folding and Aggregation Properties of Alzheimer Amyloid-β Peptides Aβ40 and Aβ42Journal of Biological Chemistry, 2006
- Inhibition of Amyloid Fibril Formation and Cytotoxicity by Hydroxyindole DerivativesBiochemistry, 2006
- Antioxidants induce different phenotypes by a distinct modulation of signal transductionFEBS Letters, 2002